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Abstract
Background: Hormones are critical for early gonadal development in nonmammalian vertebrates, and oestrogen is
required for normal ovarian development. In contrast, mammals determine sex by the presence or absence of the
SRY gene, and hormones are not thought to play a role in early gonadal development. Despite an XY sex-
determining system in marsupial mammals, exposure to oestrogen can override SRY and induce ovarian
development of XY gonads if administered early enough. Here we assess the effect of exogenous oestrogen on
the molecular pathways of mammalian gonadal development.
Results: We examined the expression of key testicular (SRY, SOX9, AMH and FGF9) and ovarian (WNT4, RSPO1,
FOXL2 and FST) markers during gonadal development in the marsupial tammar wallaby (Macropus eugenii) and
used these data to determine the effect of oestrogen exposure on gonadal fate. During normal development, we
observed male specific upregulation of AMH and SOX9 as in the mouse and human testis, but this upregulation
was initiated before the peak in SRY expression and 4 days before testicular cord formation. Similarly, key genes for
ovarian development in mouse and human were also upregulated during ovarian differentiation in the tammar. In
particular, there was early sexually dimorphic expression of FOXL2 and WNT4, suggesting that these genes are key
regulators of ovarian development in all therian mammals. We next examined the effect of exogenous oestrogen
on the development of the mammalian XY gonad. Despite the presence of SRY, exogenous oestrogen blocked the
key male transcription factor SOX9 from entering the nuclei of male somatic cells, preventing activation of the
testicular pathway and permitting upregulation of key female genes, resulting in ovarian development of the XY
gonad.
Conclusions: We have uncovered a mechanism by which oestrogen can regulate gonadal development through
the nucleocytoplasmic shuttling of SOX9. This may represent an underlying ancestral mechanism by which
oestrogen promotes ovarian development in the gonads of nonmammalian vertebrates. Furthermore, oestrogen
may retain this function in adult female mammals to maintain granulosa cell fate in the differentiated ovary by
suppressing nuclear translocation of the SOX9 protein.
See commentary: http://www.biomedcentral.com/1741-7007/8/110
Background
During vertebrate evolution, there has been a distinct
switch from a strong hormonal influence on sex deter-
mination to a genetic switch mechanism. In nonmam-
malian vertebrates, oestrogen administration to male
embryos, or blocking oestrogen production in female
embryos, results in sex reversal [1]. In contrast, in mice,
oestrogen does not affect the early development of
either ovaries or testes, and in its absence, gonadal
development proceeds normally until after birth [2].
Although the role of oestrogen in determining gonadal
fate differs between vertebrates, the downstream path-
ways of gonadal differentiation are highly conserved. In
particular, SOX9, the key regulator of testicular differen-
tiation, appears to have similar functions in all verte-
brates [3], starting with cytoplasmic expression in the
indifferent gonad, but translocating to the nucleus in
males to activate the testicular pathway [4-6]. In oestro-
gen-deficient female mice (made by deletion of one or
both oestrogen receptor genes or of the Cyp19A1 gene
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dually lost from pubertal ovaries concomitant with
remodeling of the somatic tissue. There is also transdif-
ferentiation of the ovarian granulosa cells to form testi-
cular Sertoli-like cells that express SOX9 and align in
structures resembling testicular cords [7]. This pheno-
type can be reversed by administration of oestrogen,
causing the somatic cells to reform granulosa cells and
resulting in an ovarian architecture and suppression of
SOX9 [7]. These data show that although oestrogen is
not required for early ovarian development in mice, it is
critical for maintaining ovarian somatic cell fate in the
differentiated gonad.
How and why oestrogen became dissociated from sex
determination in mammals is unknown. A genetically
controlled sex determination mechanism may have
evolved in mammals to protect the young developing
in utero from the effect of large quantities of oestrogen
in the fetoplacental unit [8,9]. However, oestrogen
receptor expression is maintained in the indifferent
mammalian gonad [10,11] despite their apparent lack of
function, and exposure of gonads to exogenous oestro-
gen activates the translocation of the receptors to the
nuclei of indifferent gonadal cells [12]. Not surprisingly,
the mammalian placenta is highly effective in metaboliz-
ing hormones before they reach the developing fetus
[13], protecting it from maternal influences. Marsupial
mammals are born with undifferentiated gonads that
undergo gonadal sex determination postnatally [14],
allowing daily administration of oestrogen directly to
developing male young from before the testis pathway is
initiated. Oestrogen treatment of XY young in the opos-
sum and in the tammar wallaby directs the development
of the indifferent gonads towards an ovarian differentia-
tion fate [15-21], including entry of the XY germ cells
into meiosis, despite the presence of a Y-chromosome
and SRY [17-19,21].
The sex-reversing effects of exogenous oestrogen on
the marsupial XY gonad are time-dependent [17,18],
just as there is a critical time window of Sry action in
the mouse [22]. Complete ovarian formation with germ
cells arrested in meiosis was seen only in animals that
were born about 1 day prematurely in a 26.5-day preg-
nancy in the tammar [18,21] and one half to 1 day pre-
maturely in the 13.5-day gestation in the opossum [17].
Treatment of animals born after a full-term pregnancy
with the same dose of oestrogen did not affect testicular
development and resulted in only minor disruption of
the testis in both species [17-19].
These findings suggest that there is a critical point in
development when the XY gonad becomes irreversibly
committed to a testicular fate. In the tammar, this coin-
cides with the first morphological signs of Sertoli cell
development and seminiferous cord formation, which
occurs after birth from a normal full-term pregnancy
[14]. To promote ovarian development, oestrogen must
be administered before the somatic cell lineage has
initiated Sertoli cell development. Early experiments
treating opossums with large amounts of androgens did
not affect gonadal development of male or female young
[15,16]. Similarly, in the tammar, testosterone adminis-
tration to male pouch young had no visible effect on
testicular structure, although oestrogen given after testes
development was initiated did cause a small degree of
testicular dysgenesis [20]. Identical findings have also
been reported in nonmammalian vertebrates in which
administration of oestrogen to the indifferent gonad can
actively induce ovarian development, independent of
genetic or environmental sex-determining factors [1,23],
whereas exogenous androgen treatment does not affect
testicular development [23]. The effects of oestrogen are
mediated through the oestrogen receptors (ERs) in the
gonad [2]. Treatment of the tammar XY gonads at day
25 of gestation with oestrogen in culture causes the oes-
trogen receptors to move from a cytoplasmic to nuclear
localization within the cell, consistent with their activa-
tion and ability to affect gene transcription in an oestro-
gen-dependent manner [12]. The nuclear translocation
of both receptor proteins in the presence of exogenous
oestrogen in culture confirms the ability of the receptors
to respond functionally to the ligand, even at early
developmental stages [12]. Thus the observed effects of
exogenous oestrogen are oestrogen-, and not steroid-,
specific.
The genes controlling sex determination are conserved
between eutherian and marsupial mammals. SRY and
SOX9 are expressed in the developing Sertoli cells of the
XY eutherian and marsupial testis [4,24,25]. These cells
direct the development of the testicular architecture and
secrete AMH, a hormone necessary for the regression of
the Müllerian ducts [26-28]. In the absence of SRY in
developing XX gonads, SOX9 levels are significantly
lower [4,25], AMH is not activated and the Müllerian
ducts remain intact [26,27]. FGF9 may also be important
for Sertoli cell specification [29] and shares an antago-
nistic relationship with an ovarian differentiation gene,
WNT4 [30]. Other key ovarian development genes
include FOXL2, RSPO1 and FST, which are upregulated
in the somatic cells of the early developing ovary in
mice and humans [31-33]. Disruption of each gene dra-
matically affects ovarian differentiation and can lead to
varying degrees of testicular development in XX mam-
mals [31-33].
To determine the molecular changes occurring during
oestrogen -induced sex reversal of XY gonads, we inves-
tigated the expression of key male and female differen-
tiation factors (SRY, SOX9, AMH and FGF9 and key
ovarian markers FOXL2, FST, RSPO1 and WNT4) in our
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period of gonadal differentiation and after oestrogen-
induced sex reversal. Here we show that exposure of the
indifferent XY gonad to oestrogen resulted in suppres-
sion of SRY and AMH and upregulation of FOXL2 and
WNT4, thus diverting the male developmental pathway
into the female one. The SOX9 gene was not downregu-
lated by oestrogen exposure during XY ovarian develop-
ment, but SOX9 protein was prevented from entering
the nucleus of the supporting cells in the presence of
oestrogen and therefore could not activate the male
developmental program. We hypothesise that this novel
function of oestrogen in modulating the nucleocytoplas-
mic localization of SOX9 may reflect an ancestral pri-
mordial mechanism by which oestrogen mediates sex
d e t e r m i n a t i o ni nn o n m a m m a l i a nd e v e l o p m e n t .H o w -
ever, oestrogen retains an important function in adult
female mammals by maintaining granulosa cell fate in
the differentiated ovary by suppressing nuclear localiza-
tion of the SOX9 protein.
Results
Molecular development of the marsupial gonad mirrors
that of the eutherian gonad
We used quantitative polymerase chain reaction (qPCR)
to examine the normal expression profiles of key male
and female gonadal differentiation genes during early
t e s t i c u l a ra n do v a r i a nd e v e l o p m e n tf r o md a y2 5o f
gestation (-1 day relative to birth) through day 10 post-
partum in the tammar wallaby (n ≥ 5 per sex per stage).
The molecular control of testicular development in the
developing tammar was similar to that of the mouse
a n dh u m a n ,e x c e p tt h a tt h ef i r s ts i g n so fs e x u a l l y
dimorphic expression of SOX9 and AMH preceded the
peak in SRY expression and testicular differentiation.
SRY (Fig. 1a) expression increased from day 24 of gesta-
tion (-2 days relative to birth) in XY gonads and reached
a peak at day 1 postpartum (pp) around the time of tes-
ticular cord formation. SRY levels then fell sharply as in
the mouse [34,35] and human [36]. In tammar males,
SOX9 (Fig. 1b) rose in the gonad, initially in concert
with SRY, but continued to increase after SRY expres-
sion fell, consistent with its suggested autoregulation
[37]. SOX9 was significantly higher in males than in
females from day 24 of gestation (P = 0.001; Additional
File 1), 4-5 days before the onset of testis cord forma-
tion, consistent with its activation by SRY binding to the
conserved testis-specific enhancer element TESCO in
the SOX9 promoter, that is found in marsupials as well
as in eutherians [3,37]. In female gonads, SOX9 levels
declined relative to levels in the testes, presumably due
to the absence of SRY. SOX9 levels were lowest in
females at day 1-2 pp (the time of cord formation in
testes) and remained consistently lower in the ovary
throughout development. AMH expression (Fig. 1c) was
identical at day 24 of gestation in XX and XY gonads,
but became significantly lower in ovaries (P = 0.0002;
Additional File 1) by day 26 of gestation, the day of
birth. The sexual dimorphism in AMH expression is
consistent with reduced SOX9 expression in XX com-
pared to XY gonads by day 26 of gestation (P = 0.0001).
AMH levels remained significantly lower in ovaries than
in testes throughout the period of development exam-
ined. FGF9 expression (Fig. 1d) was unexpectedly higher
in females than in males during very early testis cord
formation (days 1-3 pp; P < 0.01) but reached peak
expression above that seen in the ovary by day 4 pp (P
<0 . 0 1 ) .T h i si sc o n c o m i t a n tw i t had r o pi nWNT4
expression at this stage (Fig. 1h), further supporting an
antagonistic interaction between these two genes in the
gonad [30]. FOXL2 (Fig. 1e) was significantly lower in
males than in females over the entire period examined
(P <0 . 0 1 ) ,c o n s i s t e n tw i t he x p r e s s i o ns e e ni nt h ed e v e l -
oping mouse gonads [38], which suggests a conserved
early role for this gene in mammalian ovarian develop-
ment. FST expression (Fig. 1f) was not significantly
lower in developing testes than in ovaries during early
development but became significantly upregulated in
developing ovaries after day 5 pp (P <0 . 0 0 4 )d u r i n gt h e
time of ovarian differentiation. RSPO1 (Fig. 1g) was not
significantly lower in males than in females during early
gonadal development. However, on day 4 pp, RSPO1
levels dropped in females and were significantly higher
in males (P < 0.007). After day 4 pp, levels dropped in
males and increased in females during the key window
of ovarian differentiation. WNT4 expression (Fig. 1h)
was generally higher in females than in males but this
was only significant after day 4 pp, again during the
time of active ovarian differentiation, as seen for FST
and RSPO1. P values were significantly different at
almost all time points for FOXL2, FST, AMH and SOX9
(Additional File 1).
Exogenous oestrogen causes development of ovarian
structures in XY gonads
To verify that exogenous oestrogen would cause gonadal
sex reversal in culture as it does in vitro [18], we exam-
ined the histological organization of the gonads from
two control and two oestrogen-treated XY gonads after
incubation in either control or oestrogen-supplemented
media. Gonads were collected at day 25 of gestation,
just before gonadal sex determination and birth. Gonads
placed in control media and grown for 5 days had nor-
mal testicular architecture with the formation of semini-
ferous cords lined with Sertoli cells, encapsulating the
germ cells (Fig. 2, top). Conversely, XY gonads cultured
in the presence of oestrogen did not develop testicular
cords and instead the gonads took on an ovarian
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between the cortex and medulla (Fig. 2, bottom).
Exogenous oestrogen has a dramatic effect on the
testicular differentiation pathway
We next investigated the effect of sex reversal on the
expression of key testicular genes in 10 pairs of null
control and oestrogen-treated XY gonadal cultures by
quantitative PCR. In the control gonads, the levels of
SRY, SOX9 and AMH were comparable to those in vivo,
demonstrating that the gonads developed normally in
culture. However, the mRNA levels of both SRY (P <
0.001) and AMH (P < 0.001) were significantly reduced
in XY gonads cultured in the presence of oestrogen (Fig.
3a, Additional file 2). FGF9 levels were also suppressed
in oestrogen-treated gonads, although levels were not
significant (P < 0.06; Additional file 2). In contrast,
SOX9 mRNA levels did not differ significantly (P >0 . 5 )
as a result of the treatment (Fig. 3a), despite the devel-
opment of ovarian architecture. This was unexpected
Figure 1 Quantitative mRNA expression for SRY, SOX9, AMH, FGF9, FOXL2, FST, RSPO1 and WNT4 during normal male (solid circles)
and female (open circles) gonadal differentiation. Dotted line indicates day of birth, grey shading in a-d indicates the period of testis
patterning and grey shading in e-h indicates the window of ovarian patterning. The critical period of testicular differentiation occurs between
day 25 of gestation and day 2 postpartum, and that of ovarian differentiation between days 6-10 postpartum. P values from t-tests conducted to
examine whether expression levels of the various genes were significantly different between males and females at each data point are shown in
Additional file 1. Raw data for the mean ΔCt and standard deviations for each data point are shown in Additional file 5.
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eutherian mammals [39,40].
SOX9 protein remains cytoplasmic in the presence of
oestrogen
As a transcription factor, it is not just the level of SOX9,
but also its subcellular localization that is essential for
its function in initiating testicular development [4]. We
therefore investigated SOX9 protein distribution using
immunocytochemistry in two control and two oestro-
gen-treated XY gonads. In control XY gonads, SOX9
was almost entirely nuclear and restricted to the Sertoli
cells of the developing testis, consistent with its distribu-
tion seen during normal in vivo development [25] (Figs.
4a and 4b). However, XY gonads cultured in the pre-
sence of oestrogen had diffuse SOX9 staining that was
restricted to the cytoplasm of gonadal cells and did not
enter the nuclei (Figs. 4c and 4d). Since SOX9 levels
were sexually dimorphic before gonadal differentiation,
we also investigated protein distribution at day 25 of
gestation (the first day of culture). At this stage, SOX9
had a strong cytoplasmic distribution but had become
nuclear in a subset of somatic cells (Additional file 3).
Exogenous oestrogen activates the female differentiation
pathway
In addition to the downregulation of testicular genes,
oestrogen exposure and lack of nuclear SOX9 in the
tammar sex-reversed XY gonads led to an upregulation
of the key ovarian differentiation genes FOXL2 (P <
0.004) and WNT4 (P < 0.02) (Fig. 3b, Additional file 1),
consistent with findings that both genes are critical early
regulators of ovarian development [31,33,38]. In tammar
sex-reversed gonads, FGF9 was downregulated in con-
cert with WNT4 upregulation, supporting a conserved
antagonistic interaction between these two genes in
mammalian gonadal differentiation [30]. RSPO1 was sig-
nificantly downregulated (P < 0.001) in the presence of
oestrogen, consistent with the normal expression of this
gene at day 4 pp in males and females, suggesting that
at this stage of development, RSPO1 i sn o tr e q u i r e df o r
marsupial ovarian differentiation. FST mRNA expression
was not significantly altered by oestrogen treatment (P >
0.5; Fig. 3b and Additional file 2).
Discussion
Marsupials occupy a unique evolutionary niche and can
provide important information on the evolution and
conservation of mammalian developmental pathways.
This is the first comprehensive study of the expression
levels of key testicular and ovarian genes during gonado-
genesis in any marsupial. During normal development in
the tammar gonad, expression of key male development
genes is similar to that seen in the mouse and human,
except that AMH and SOX9 show sexually dimorphic
gene expression before the peak in SRY expression at
Figure 2 Structure of control and oestrogen-cultured gonads. Oestrogen-cultured XY gonads developed ovarian-like cortical and medullary
structures with germ cells distributed at the periphery of the cortex (arrowhead), while control gonads developed normal testicular architecture
with germ cells confined to testis cords. Gonad plus mesonephros (meso)complexes were sectioned at 8 μm and stained with Mallory’s triple
stain. Top: Gonads cultured in control media. Bottom: Gonads cultured in the presence of oestrogen. Control XY gonads have normal male
development with the formation of seminiferous cords (SC; outlined by dashed line) delineated by a basal lamina (stained dense blue) with the
germ cells contained within these structures. Oestrogen-treated XY gonads formed a cortex (C) which contained germ cells and a central
medulla (M), resembling the normal ovarian architecture of equivalent stage XX gonads.
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nuclear translocation 3 days before the peak in SRY
expression and the appearance of testicular cords. This
m a yb et h er e s u l to ft h el o n gp e r i o do fSRY expression
seen in marsupials [24], similar to that of human XY
gonads [36] but different from the ultrashort pulse seen
in mice [34,35]. The key female development genes
FOXL2 and WNT4 were upregulated in the XX gonad
during the time of ovarian development (5-10 days pp).
However, RSPO1 and FST expression was variable in the
early gonad, and female-specific upregulation was seen
only during the later stages of ovarian development.
This observation suggests that these two genes act
downstream of FOXL2 and WNT4 in the ovarian differ-
entiation pathway, at least in the tammar.
Cultured XY control gonads had normal male expres-
sion profiles and formed testicular cords. However, XY
gonads cultured in the presence of oestrogen failed to
upregulate SRY and AMH expression and instead upre-
gulated FOXL2 and WNT4. The oestrogen-exposed XY
gonads also developed ovarian architecture, confirming
that female development had occurred. Surprisingly,
mRNA levels for SOX9, the key factor essential for testi-
cular development, did not differ between control and
treated XY gonads, despite ovarian development. To
investigate this further, we examined the protein locali-
sation of SOX9 in control and oestrogen-treated XY
gonads. Since SOX9 is a transcription factor, nuclear
localisation is essential to activate the male developmen-
tal program and SOX9 mutations that affect nuclear
import result in XY sex reversal in humans [41,42]. In
the mouse and human, the SOX9 protein is initially
cytoplasmic in the indifferent gonad of both XX and XY
fetuses, but becomes rapidly nuclear and upregulated
only after the peak of SRY expression in testes, whereas
in ovaries, Sox9 remains cytoplasmic and is lost [4,5]. In
the clawed toad, Xenopus, SOX9 also remains cytoplas-
mic in developing ovaries but becomes nuclear under
testis-promoting conditions in the absence of oestrogen
and is upregulated [6,43]. However, in the presence of
oestrogen under ovary-promoting conditions, SOX9
remains cytoplasmic and is downregulated.
In mice, Sry initiates Sox9 upregulation within pre-
Sertoli cells. Sox9 then autoregulates to reach threshold
levels that activate testicular development [44]. In the
tammar, SRY had initiated SOX9 upregulation before
the cultures began (Fig. 1; Additional file 1) and before
the peak in SRY expression 3 days later. Thus oestrogen
exposure at this time (day 25 of gestation) did not pre-
vent the initial wave of SOX9 mRNA upregulation, but
the protein was restricted to the cytoplasm of somatic
cells, preventing its activation of the male pathway and
likely its self-propagated upregulation. This observation
explains the initiation of ovarian development in the
treated XY gonads in this in vitro s t u d ya n di nt h ee a r -
lier in vivo studies [17,18,21]. Treatment of developing
turtle gonads with oestrogen at stages of development
before gonadal sex determination had occurred (and
prior to the initialu p r e g u l a t i o no fSOX9)p r e v e n t e d
SOX9 from becoming upregulated to equivalent male or
even female levels [45]. These findings suggest that
there is also a direct action of oestrogen in repressing
SOX9 t r a n s c r i p t i o ni nt u r t l e s ,a sw eh a v eo b s e r v e di n
the tammar. Interestingly, in the turtle, SOX9 protein is
nuclear in female gonads before sex determination. We
see a similar nuclear localization in the indifferent
gonad in the tammar wallaby (Additional file 3).
Figure 3 Gene expression in XY oestrogen-treated gonads
cultured from day 25 of gestation for 5 days. Quantitative PCR
for key male markers SRY, SOX9, AMH and FGF9 (a), and key female
markers FOXL2, RSPO1, WNT4 and FST (b) during gonadal culture in
control (open bars) and oestrogen-treated (black bars) gonads. Both
SRY and AMH mRNA levels were significantly suppressed (P < 0.001)
in the sex-reversed gonads. However, SOX9 mRNA levels were
unchanged (P > 0.5). There was significant upregulation of the
ovarian genes FOXL2 (P < 0.004) and WNT4 (P < 0.02) in sex-
reversed gonads, while FST was unchanged and RSPO1 was
significantly downregulated (P < 0.001) in the presence of
oestrogen.
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early stages of gonadal development, SOX9 can feely
translocate to the nucleus of somatic cells. In mammals,
SOX9 expression is reinforced by SRY, upregulating it
above threshold levels enabling it to autoregulate and
initiate testicular development. In nonmammalian verte-
brates, the oestrogen production could act to directly
suppress SOX9 upregulation and promote ovarian devel-
opment. Our results show that oestrogen restricts trans-
location of the SOX9 protein, forcing it to remain in the
cytoplasm and prevent its self-propagated upregulation.
Since SOX9 mRNA is never elevated above basal levels
in the oestrogen-treated male turtle, the effect of oestro-
gen on its subcellular localization cannot be observed in
their gonads. However, in our study, we administered
oestrogen slightly later in development, just after the
initial wave of SOX9 upregulation. Our results therefore
highlight a mechanism by which oestrogen could pre-
vent testicular development (Fig. 4). The exclusion of
SOX9 from somatic cell nuclei of the oestrogen cultured
gonads is further confirmed by the failure of AMH upre-
gulation because in the mouse, Sox9 acts as a nuclear
transcription factor to drive Amh expression [46].
In the absence of nuclear SOX9 in XY oestrogen-trea-
ted gonads, female development was initiated. FOXL2
was significantly upregulated, consistent with an early
and essential role for this gene in initiating ovarian
development in mammals. In goats, FOXL2 induces aro-
matase (CYP19) expression, leading to oestrogen pro-
duction in the developing ovary [38]. This mechanism
could potentially ensure a block in male development by
excluding SOX9 nuclear entry. This mechanism could
work in synergy with activated ERs to facilitate FOXL2
binding to TESCO, further suppressing SOX9 mRNA
Figure 4 The distribution of SOX9 protein in oestrogen-treated and control cultures. Immunohistochemistry showing the subcellular
distribution of SOX9 in control and oestrogen cultured XY gonads, using AEC+ chromogen red/brown staining (Dako) and counterstained with
haematoxylin (blue). In the culture controls (a; magnified in b) localization was nuclear (black arrowhead) and confined to the Sertoli cells of the
developing seminiferous cords. In contrast, in the oestrogen-cultured gonads (c; magnified in d), SOX9 was largely cytoplasmic (red arrowheads)
and no or very few nuclei were stained. Scale bars are 100 μm in (a) and (b) and 25 μm in (c) and (d).
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the oestrogen response elements contained within the
mouse TESCO element [37] do not fall into the evolu-
tionarily conserved regions identified in most vertebrates
[3], suggesting that this mechanism of oestrogen action
may not be as important as its role to prevent SOX9
from entering the nucleus.
Several lines of evidence demonstrate that oestrogen
acts as a modulator of the subcellular localization of
SOX9. Sox9 is produced at a low level in the somatic cells
of the adult mouse ovary [47], but its self-propagated
upregulation is somehow blocked. Our findings suggest
that circulating oestrogen could prevent the nuclear trans-
location of SOX9 in differentiated ovarian somatic cells,
thus preventing its own upregulation. In the absence of
oestrogen in female aromatase-deficient knockout mice,
Sox9 is upregulated in ovarian somatic cells, as it can pre-
sumably translocate to the nucleus to propagate its own
transcription. However, when exogenous oestrogen is
administered to aromatase-deficient mice, this effect is
reversible and Sox9 is repressed [5,48]. This mechanism
therefore explains how Sox9 upregulation is able to occur
in the oestrogen-deficient mouse ovary and how it can be
subsequently suppressed with somatic cell transdifferentia-
tion in the presence of exogenous oestrogen. These find-
ings suggest that in mammals, oestrogen may still be a
critical factor regulating ovarian somatic cell fate mainte-
nance by preventing SOX9 nuclear translocation.
This fundamental role of oestrogen can explain its
sex-determining ability in nonmammalian vertebrates.
SOX9 remains cytoplasmic in the developing ovaries of
nonmammalian vertebrates in the presence of oestrogen
[5]. However, in the absence of oestrogen, SOX9
becomes nuclear and testicular development is initiated
[41]. Our findings suggest that this may be a universal
action of oestrogen in all vertebrates.
How oestrogen prevents SOX9 from entering the
nucleus is still unknown. There are several known path-
ways that control SOX9 nuclear entry, such as altered
importin-b1 or calmodulin binding, both of which facili-
tate effective transport of SOX9 across the nuclear pore
complex [41,42]. In addition, sumoylation and/or ubi-
quitination also affect the subcellular localization and
transcriptional activity of SOX9 [49,50]. Oestrogen is
known to directly affect sumoylation and the subcellular
localization of the nuclear receptor coactivator family
member 3 protein in breast cancer cell lines [51]. Oes-
trogen may work in a similar way in the gonad by mod-
ulating sumoylation and/or ubiquitination of the SOX9
protein, trapping it in the cytoplasm.
Conclusions
We have uncovered a mechanism using a marsupial
model that provides a link between mammalian and
nonmammalian vertebrate sex determination mechan-
isms (Fig. 5). We have shown that exogenous oestrogen
can inhibit the nuclear translocation of SOX9, blocking
testicular development in an XY mammalian gonad. As
a result, ovarian differentiation occurred, concomitant
with upregulation of FOXL2 and WNT4 (Fig. 3). We
propose a model in which the role of oestrogen is to
modulate the subcellular localization of SOX9 (Fig. 5).
This could be an underlying and ancestral mechanism
that controls ovarian development in nonmammalian
vertebrates. In the absence of oestrogen in developing
male fetuses, SOX9 would become nuclear and initiate
testicular differentiation. However, in those nonmamma-
lian vertebrates destined to become females, expression
of aromatase and the production of oestrogen could
prevent the nuclear translocation of SOX9, thus actively
blocking testicular development. In mammals, the reten-
tion of this mechanism is not an evolutionary remnant
of past function, but may have been retained to ensure
that SOX9 nuclear entry is suppressed in the mature
ovary to maintain granulosa cell fate.
Methods
Gonadal Culture
XY gonadal ridges (gonad and mesonephros taken
together) were cultured in pairs from late-stage male
tammar wallaby fetuses. The tammar wallaby gonadal
ridge first develops on day 21 of the 26.5-day gestation
period [14]. Seminiferous cords do not form in testes
until day 2 pp, and ovarian differentiation is first seen
around day 8 pp [14]. A total of 12 male fetuses were
collected at day 25 of gestation, and pairs of gonads
were isolated and placed, one into control media and
the other into oestrogen media. Gonads were cultured
for 5 days (120 hr) as previously described [12], with
either Dulbecco’s modified Eagle medium (DMEM)/
10% fetal calf serum (FCS)/50 mg/ml ampicillin (con-
trol) or with the addition of estradiol benzoate (to a
final concentration of 100 ng/ml). This dose was cho-
sen to ensure sufficient oestrogen penetration into the
cultured gonad. Estradiol benzoate was diluted in
100% ethanol at 1 mg/ml, and an equivalent amount
of ethanol (without estradiol) was added to control
cultures. At the conclusion of the culture period,
gonads were either fixed in 4% paraformaldehyde and
processed for histology or snap-frozen for molecular
analyses.
Histology
Two of the 12 control and two of the 12 oestrogen-trea-
ted XY cultured gonads were sectioned (8 μm) and
stained with Mallory’s triple stain to highlight the basal
lamina (bright blue) in the developing gonads, according
to standard methods.
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Anti-SOX9 antibody (Ab5535; Chemicon) was used at
1:100 dilution. Slides were then incubated with goat
anti-rabbit biotin-conjugated secondary antibody (Mole-
cular Probes). The avidin-biotin complex (ABC) kit
(Vector Laboratories) was used according to the manu-
facturer’s instructions, and antibody binding was visua-
lized with the AEC+ chromogen (Vector Laboratories).
Negative controls were performed as described above
with the omission of the primary antibody and an
equivalent amount of nonspecific IgG from the same
species. No staining was observed in negative controls.
Sections were counterstained with haematoxylin.
RNA extraction and cDNA synthesis
RNA was extracted from gonads using the GenElute™
Mammalian Total RNA Miniprep Kit (Sigma) as per the
manufacturer’s instructions. Total RNA was DNase trea-
t e du s i n gt h eT u r b oD N Af r e e( A m b i o n )a sp e rt h e
manufacturer’s instructions. Complementary DNA was
produced using the Superscript III First Strand Synthesis
System for reverse transcriptase (RT)-PCR (Invitrogen)
to generate the first strand according to the manufac-
turer’s instructions.
Quantitative polymerase chain reaction
qPCR was carried out using the Quantitect real-time
master mix (Qiagen) on a Bio-Rad CFX96 PCR machine.
The genes of interest were normalized against b-actin
expression using the ΔCT method described by Pfaffl
[52] and taking primer efficiency into account. Standard
t-tests (for sex reversal data; two-tailed, paired [gonad
pairs; one cultured in oestrogen and the other in control
media], for normal male profile; two-tailed, homoscedas-
tic [comparing equal numbers of male and female
gonads at different time points]) were used to compare
the data sets using Microsoft Excel. For the normal gene
expression profiles, data are shown relative to b-actin
with individual gonads (n ≥ 5) at each developmental
time point for each sex. For gonadal culture, the
remaining 10 gonadal pairs that were cultured were ana-
lyzed (20 gonads; 10 control and 10 oestrogen-cultured).
The expression was normalized relative to b-actin.
Expression levels in control gonads were designated
100%, and expression in the oestrogen-treated gonads
expressed relative to control levels for each gene was
examined. All real-time PCR reactions were subject to
melt curve analysis and gel electrophoresis to check for
single-product amplification. The primers chosen for
amplification are listed in Additional file 4.
All experimental procedures conformed to Australian
National Health and Medical Research Council (2004)
guidelines and were approved by the University of Ani-
mal Experimentation Ethics Committees. Husbandry of
tammar wallabies (Macropus eugenii)a sw e l la sa g i n g
and sexing of pouch young and fetuses were carried out
as previously described [14].
Additional material
Additional file 1: Statistical difference between male and female
data points shown in Figure 1. P values (from t-tests) are listed for all
data points shown in the normal expression profiles for SOX9, AMH, FGF9,
FOXL2, FST, RSPO1, WNT4. Gene name is given in the top left hand corner
of each data set. Column 2 shows the stage of development; d = day of
gestation, D = postnatal day. Column 3 shows the P value from a two
tailed, homoscedastic t-test (conducted in Microsoft Excel). Significant
values (P ≤ 0.05) are highlighted in yellow. The bottom row (combined
M (male) v F (female)) shows the P values for the entire male versus
female data set combined across the time period shown. SOX9, AMH,
FOXL2 and FST showed the greatest difference between testes and
ovaries. WNT4 was significantly higher in females than males over the
entire period examined, but was not significantly higher at any given
time point.
Additional file 2: Raw expression data for qPCR analysis of the
oestrogen-treated and control culture gonads. Graphs show
expression relative to beta-actin (house keeping control gene) that
shows high levels of expression. Small bars represent a small difference
between target gene expression and that of beta-actin (thus, represent
high expression values) while large bars show a greater difference
between target gene levels and beta-actin (thus, representing low
expression values). Error bars show one standard deviation either side of
the mean.
Additional file 3: SOX9 distribution in the bipotential gonad.S O X 9
protein was examined in the day 25 fetal XY gonad to determine its
distribution at the start of the culture period. At this time, SOX9 was
already localized in the nuclei (black arrowhead) of many somatic cells,
but some weak cytoplasmic staining (red arrowhead) also remained.
SOX9 
estrogen 
Sox9  TESCO 
ER 
SOX9 
estrogen 
Sox9  TESCO 
ER 
Granulosa cell fate  Sertoli cell fate 
Figure 5 Model for the role of oestrogen and the gonadal
determination pathway. In normal XY gonads, the somatic cells
upregulate SRY, which in turn upregulates SOX9. SOX9 can then
translocate to the nucleus and activate the expression of AMH to
ensure normal male urogenital development. In the presence of
oestrogen, the bipotential somatic cell is instead directed into the
granulosa cell pathway. SRY fails to upregulate, and any SOX9
protein produced fails to enter the nucleus. In the absence of
nuclear SOX9, AMH fails to upregulate and ovarian genes (FOXL2
and WNT4) are activated. Exogenous oestrogen therefore has the
ability to direct XY bipotential somatic cells to a granulosa cell fate.
Oestrogen may act in a similar manner to maintain granulosa cell
fate in mature eutherian ovaries, preventing basal levels of SOX9
protein from translocating to the nucleus and propagating its own
upregulation.
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Page 9 of 11Additional file 4: Primers used. Primers used in quantitative PCR
reactions are listed in 5’ to 3’ orientation.
Additional file 5: Raw expression data for qPCR analysis of the
normal gene profiles shown in Figure 1. Mean delta Ct values and the
standard deviation (std-dev) for each data point shown in Figure 1. The
housekeeping gene b-actin shows high levels of expression so most
delta Ct values are negative. The left column represents data points from
the male profile and the right column represents data points from the
female profile. Gene names are indicated in the top left corner of each
table. Graphed data is log transformed and shown relative to beta actin
in Figure 1.
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